Home › Brain Diseases › Ohio
Brain Diseases clinical trials in Ohio
7 studies for Brain Diseases are looking for participants at sites in Ohio.
Cities in Ohio
CoMind Early Feasibility Study
- Ohio State University, Columbus
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT06368648A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #051, Canton
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 11, 2026 · NCT07804615Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- Miami Valley Hospital South, Centerville
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT05386108A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, North Canton
- Clinical Site, West Chester
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 1, 2026 · NCT07459647A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Dayton
- Clinical Site, Independence
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Aug 27, 2026 · NCT06887192North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
- Akron Children's Hospital, Akron
- Cleveland Clinic, Cleveland
- Case Western Reserve University, Clevland
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Feb 4, 2026 · NCT01694940Epilepsy Learning Healthcare System (ELHS)
- Akron Children's Hospital, Akron
- Cincinnati Children's Hospital Comprehensive Epilepsy Center (CCHMC), Cincinnati
- University of Cincinnati Gardner Neuroscience Institute Epilepsy Center, Cincinnati
RecruitingObservational study
All ages · All sexes · Updated Aug 30, 2024 · NCT06265103From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.